Agilent Receives Multiple Life Science Industry Awards for Innovation
November 26 2019 - 8:00AM
Business Wire
Recognizing innovation and excellence in the life science
industry
Agilent Technologies Inc. (NYSE: A) announced today that it has
received two Life Science Industry Awards (LSIA) for ‘Most
Innovative New Products in 2019’ from BioInformatics Inc. Since
2002, the LSIA have recognized manufacturers of the ‘tools of
science’ that help advance biological research and drug
discovery.
The Agilent products were the Magnis NGS Prep System, which
received a Silver Award in the genomics category, and the
xCELLigence RTCA eSight, which received a Bronze Award in the cell
analysis category. Agilent was the only life sciences company
nominated twice.
“I’d like to congratulate Agilent for winning not one, but two,
Life Science Industry Awards in the categories of cell biology and
genomics," said Craig Overpeck, CEO of BioInformatics Inc.
“xCELLigence RTCA eSight and the Magnis NGS Prep System are
examples of Agilent’s innovative thinking and commitment to driving
life science research forward.”
The fully automated Magnis NGS Prep System includes reagents and
protocols that make it easy to assay multiple genes and complex
genetic aberrations from genomic DNA, including degraded samples
such as formalin-fixed paraffin-embedded (FFPE).
“With complex NGS library preparation, customers often struggle
with retaining skilled lab personnel who can routinely produce
high-quality results,” said Kevin Corcoran, Agilent VP, and general
manager for biomolecular analysis. “The Magnis was designed as a
turn-key automation solution to enable any lab to adopt NGS. Magnis
has innovated library prep processing, ensuring optimized,
reproducible results that work seamlessly with Agilent’s SureSelect
platform.”
The xCELLigence RTCA eSight provides label-free, real-time
biosensor measurements, as well as kinetic imaging of the same live
cell populations, independently, or simultaneously. It enables
scientists to obtain unprecedented information and deep insight
into cell health and their responses to a variety of chemical or
biological manipulations across a wide spectrum of basic research
and therapeutics fields, including cell biology, immunology,
immuno-oncology, and immunotherapy.
"It is a great honor for our xCELLigence RTCA eSight, the latest
addition to Agilent’s cell analysis portfolio, to receive one of
the Most Innovative New Product in 2019 Award - Cell Biology from
Bioinformatics," said Xiaobo Wang, Ph.D., who joined Agilent from
ACEA, as general manager of the Flow Cytometry and Real-Time Cell
Analysis Business. "The launch of xCELLigence RTCA eSight, with its
highly multiplexing capabilities including real-time electronic
biosensor measurements and live cell imaging with up to four
independent, bright field and fluorescent channels, represents the
frontier in live cell analysis. Now researchers can observe cell
health and behavior in the greatest mechanistic details to analyze
and more fully understand complex cellular environments and
interactions through the entire course of the cell-based
assay.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. Now in its 20th
year as an independent company delivering insight and innovation
toward improving the quality of life, Agilent instruments,
software, services, solutions, and people provide trusted answers
to customers' most challenging questions. The company generated
revenue of $5.16 billion in fiscal 2019 and employs 16,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191126005181/en/
Naomi Goumillout Agilent Technologies +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2023 to Sep 2024